Europace Advance Access originally published online on April 17, 2008
Europace 2008 10(7):882-883; doi:10.1093/europace/eun090
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CASE REPORTS
New method for cardiac resynchronization therapy: transapical endocardial lead implantation for left ventricular free wall pacing
1 Gottsegen Gyorgy Hungarian Institute of Cardiology, Haller utca 29, 1096 Budapest, Hungary; 2 Department of Clinical Electrophysiology, Thoraxcentre, Erasmus Medical Center, Molewaterplein 40, kamer Ba 577, Postbus 2040, 3000 CA Rotterdam, The Netherlands
Manuscript submitted 31 January 2008. Accepted after revision 19 March 2008.
* Corresponding author. Tel: +31104633991; fax: +3612151220 ext. 413. E-mail address: t.szilitorok{at}erasmusmc.nl
| Abstract |
|---|
|
|
|---|
Coronary sinus lead placement for transvenous left ventricular (LV) pacing in cardiac resynchronization therapy (CRT) has a significant failure rate at implant and a significant dislocation rate during follow-up. For these patients, epicardial pacing lead implantation is the most frequently used alternative. The aim of this case report is to describe a fundamentally new approach for the endocardial LV lead implantation. An epicardial lead implantation was planned, but after thoracotomy, extensive pericardial adhesions were found. An active fixation lead was placed into the LV cavity using the standard Seldinger technique through the LV apex. After an uneventful post-operative period at the 3- and 6-month follow-up visits, the patient had effective CRT with unchanged pacing parameters. In conclusion, this is the very first report showing feasibility of transapical LV lead implantation.
| Introduction |
|---|
|
|
|---|
Coronary sinus lead placement for transvenous left ventricular (LV) pacing in cardiac resynchronization therapy (CRT) has a considerable failure rate at implant and a significant dislocation rate during follow-up. In order to improve the cardiac function, alternative approaches are necessary for these patients. The aim of this paper is to show a fundamentally new approach—the transapical CRT—for the endocardial LV lead implantation.
| Case presentation |
|---|
|
|
|---|
A 72-year-old male had multiple dislocations of his coronary sinus LV lead. Epicardial lead implantation was planned, but during this attempt extensive pericardial adhesions were found. On the basis of significant experience with transapical cannulation techniques, which are widely used in heart surgery (transapical left ventricular assist device (LVAD) cannula implantation, transapical aortic valve implantation, alternative valved conduit implantation between the apex and the thoracic aorta, and decompression cannula or alternative aortic cannula application during different kind of heart surgeries), transapical implantation of an endocardial pacing lead was decided. An active fixation lead was placed into the LV cavity using a simple puncture and standard Seldinger technique through the LV apex. Bleeding from the ventricle was controlled with two 5/0 monofilament purse-string sutures around the puncture point (Figure 1). Using a J shaped guide wire, the tip of the lead was positioned and fixed into the mid-lateral segment of the LV under fluoroscopy guidance. Pacing parameters were assessed and were found to be optimal. The lead was conducted through the chest wall near the apex into a subcutaneous tunnel up to the pocket of the previously implanted device. As the patient was anticoagulated before the procedure because of his impaired LV function, therefore, reintroducing the oral anticoagulation did not result in extra burden to the patient. The target anticoagulation level is identical to mechanical valve prostheses. The final result is shown in Figure 2. After an uneventful post-operative period at the 3- and 6-month follow-up visits, the patient had effective CRT with unchanged pacing parameters.
|
|
| Discussion |
|---|
|
|
|---|
The coronary sinus lead placement for transvenous LV pacing in CRT has a failure rate at implant and at short-term follow-up between 10 and 15%.1
The transapical endocardial lead implantation is minimally invasive and does not involve the mitral valve; therefore, the risk for mitral valve endocarditis is significantly reduced. Furthermore, transapical access allows manipulation of the lead in the LV cavity. This is done under the guidance of fluoroscopy. Theoretically, any segment of the LV can be stimulated, which is the biggest advantage when compared with the currently used alternatives. Obviously, large-scale studies are required to investigate the clinical value of this technique. In contrast, until these results will be available, this pacing modality can be used as a last resort for troubled patients if standard CRT implantation fails.
Conflict of interest: none declared.
| References |
|---|
|
|
|---|
[1] Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, MIRACLE study group, et al. Multicenter insync randomized clinical evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med (2002) 346:1845–53.
[2] Gelder BM, Scheffer MG, Meijer A, Bracke FA. Transseptal endocardial left ventricular pacing: an alternative technique for coronary sinus lead placement in cardiac resynchronization therapy. Heart Rhythm (2007) 4:454–60.[CrossRef][Web of Science][Medline]
[3] Nuta B, Lines I, MacIntyre I, Haywood GA. Biventricular ICD implant using endocardial LV lead placement from the left subclavian vein approach and transseptal puncture via the transfemoral route. Europace (2007) 9:1038–40.
[4] Kassai I, Szili-Torok T. Concerns about the long-term outcome of transseptal cardiac resynchronization therapy: what we have learned from surgical experience. Europace (2008) 10:121–2.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Maisano, I. Michev, S. Rowe, A. Addis, M. Campagnol, A. Guidotti, A. Colombo, and O. Alfieri Transapical endovascular implantation of neochordae using a suction and suture device Eur. J. Cardiothorac. Surg., July 1, 2009; 36(1): 118 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Z. Khan, M. S. Virdee, S. P. Fynn, and D. P. Dutka Left ventricular lead placement in cardiac resynchronization therapy: where and how? Europace, May 1, 2009; 11(5): 554 - 561. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



